HT
ADPT icon

Headlands Technologies’s Adaptive Biotechnologies ADPT Stock Holding History

Headlands Technologies’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+9,718
New +$149K 0.02% 600
2026
Q1 		– Sell
-55,191
Closed -$896K – 717
2025
Q4 		$896K Buy
+55,191
New +$901K 0.07% 290
2024
Q1 		– Sell
-1,818
Closed -$8.91K – 1220
2023
Q4 		$8.91K Sell
1,818
-982
-35% -$4.48K ﹤0.01% 777
2023
Q3 		$15.3K Sell
2,800
-6,732
-71% -$44.5K 0.01% 638
2023
Q2 		$64K Buy
+9,532
New +$70.9K 0.02% 444

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Headlands Technologies's ADPT Position: Q2 2026 in Review

Headlands Technologies opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 9,718 shares worth $208K. The stake represents 0.02% of the portfolio and ranks #600 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in ADPT as recently as Q4 2025.

Headlands Technologies first reported a position in ADPT in Q2 2023 and has held it in 5 quarters since. The position peaked at $896K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Headlands Technologies held 9,718 shares of Adaptive Biotechnologies worth $208K as of Q2 2026.
  • Adaptive Biotechnologies was a new Headlands Technologies position in Q2 2026.
  • Adaptive Biotechnologies made up 0.02% of Headlands Technologies's portfolio in Q2 2026, its #600 holding.
  • Headlands Technologies first reported a position in Adaptive Biotechnologies in Q2 2023 and has held it in 5 quarters since.
  • Headlands Technologies's Adaptive Biotechnologies position peaked at $896K in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.